Gene regulatory programs controlling the activation and polarization of CD4 + T cells are incompletely mapped and the interindividual variability in these programs remain unknown. We sequenced the transcriptomes of ~160k CD4 + T cells from 9 donors following pooled CRISPR perturbation targeting 140 regulators. We identified 134 regulators that affect T cell functionalization, including IRF2 as a positive regulator of Th 2 polarization. Leveraging correlation patterns between cells, we mapped 194 pairs of interacting regulators, including known (e.g. BATF and JUN) and novel interactions (e. g. ETS1 and STAT6) . Finally, we identified 80 natural genetic variants with effects on gene expression, 48 of which are modified by a perturbation. In CD4 + T cells, CRISPR perturbations can influence in vitro polarization and modify the effects of trans and cis regulatory elements on gene expression.
CD4 + T cells display an incredible degree of functional diversity during adaptive immune responses classically characterized by the expression of canonical cytokines that create systemic inflammatory responses (e.g. Th 17 ) (1-4), signal and recruit B cells (e.g. Th 1 and Th 2 ) (5) (6) (7) (8) (9) (10) (11) , and induce tolerance in the tissue microenvironment (e.g. T reg ) (12, 13) . Recently, the ability of CD4 + T cells to directly kill infected and tumor cells have also received renewed attention (14) (15) (16) . While the functionalization of CD4 + T cells is predominantly determined by the polarization of naive T cells (T naive ), recent results have suggested a high degree of variation within and plasticity between canonical subtypes (17) . Indeed, we (18, 19) and others (20) (21) (22) have shown that human circulating CD4 + T cells are composed of a mixture of canonical and non-canonical populations with significant interindividual variability in both the proportion and gene expression of each population (18) .
Key regulators of CD4 + T cell differentiation and polarization have been mapped in mice utilizing pooled and arrayed genetic screens. For example, pooled knockdown screens with RNA interference have identified Ppp2r2d as a key regulator of T cell proliferation (23) and mapped two self-reinforcing, mutually antagonistic modules of regulators that drive Th 17 differentiation (24) . More recently, a pooled genome wide CRISPR screen paired with bulk RNA sequencing identified Trappc12, Mpv17l2, and Pou6f1 as regulators of both Th 2 activation and differentiation (25) . Despite these insights, mapping gene regulatory programs that underlie human CD4 + T cell state transitions is incomplete and the intra-and inter-individual variability in these programs remain largely unknown.
Recent advances in the integration of droplet-based single cell RNA-sequencing (dscRNA-seq) and CRISPR/Cas9-mediated genome engineering has created new opportunities to assess the functional consequences of genetic perturbations in primary human T cells at an unprecedented molecular and cellular resolution (26) (27) (28) . Here, we integrate single guide RNA (sgRNA) lentiviral infection with Cas9 protein electroporation (SLICE) and multiplexed dscRNA-seq (mux-seq) to screen the effects of 140 regulators in primary CD4 + T cells across nine donors. By linking each sgRNA with the transcriptomes of hundreds of heterogeneous CD4 + cells, we map regulators that affect the activation and polarization of specific T cell subsets. By further leveraging the coexpression patterns across single cells, we define novel gene regulatory relationships between pairs of regulators and their downstream targets. Finally, by incorporating donor genetics, we identify instances where genetic effect on gene expression is modified by CRISPR perturbations. Our work demonstrates that systematic analyses using multiplexed single-cell genomics and genome engineering is a powerful approach to map the gene regulatory networks that govern the functionalization of primary human T cells and characterize the intraand inter-individual variability in these networks.
Results

CRISPR perturbation screen in activated CD4 + T cells across donors
To map gene regulatory programs that underlie the polarization and activation of human CD4 + T cells, we performed sgRNA lentiviral infection with Cas9 protein electroporation (SLICE) (28) followed by multiplexed single-cell RNA-sequencing (mux-seq). Primary CD4 + T cells were isolated from peripheral blood mononuclear cells (PBMCs) and activated in vitro as previously described (29, 30) (Fig. 1A; Methods) . Activated cells were transfected with 280 sgRNAs targeting 140 regulators that were either highly expressed (top quartile from bulk RNA-seq) or have binding sites that were differentially accessible (from bulk ATAC-seq) in activated CD4 + T cells (18) (Fig. 1B; Table 1 ; Methods). Following Cas9 electroporation and multiple rounds of selection and proliferation, activated CD4 + T cells (31) were pooled across 9 donors and profiled using the 10X Chromium platform in 16 wells resulting in 320,708 cell-containing droplets and 16,750 reads/droplet ( Fig. S1-3 ; Methods). To maximize the probability of detecting sgRNAs in cells, we further amplified and sequenced the sgRNA transcripts from the resulting 10X cDNA library to near saturation as previously described (32) (98% compared to 63% in the 3' tagged library; Fig. 1C ; Methods).
After filtering for doublets using exonic SNPs (77,046 -24%) and cells with ambiguous sgRNA assignments (79,037 cells -25%; Methods), 164,623 cells were kept for subsequent analyses corresponding to 18,291±4,571 cells per donor and 882±522 cells per sgRNA (Fig. 1C, D ; Table  2 ; Methods). Of these, 105,664, 40,960, 12,675, and 5,324 cells contained one, two, three, or four sgRNAs, resulting in an estimated multiplicity of infection (MOI) of 1 ( Fig. 1E, S4) .
To assess the cutting efficiency of each sgRNA, we sequenced the sgRNA pool and DNA of the edited cells from each donor by targeted amplification of 268/280 loci (Methods). The insertion and deletion (indel) frequencies at each targeted locus and coverage of the corresponding sgRNA in the pool are expectedly correlated (R = 0.36, P < 1.68x10 -8 , Fig. 1F ) and the average ratio between these two quantities -defined as the cutting efficiency -is 21%±15% (Fig. 1F inset) . We defined 14 sgRNAs as uncut negative controls (WT) where the ratios between the cutting efficiencies and proportion of cells containing each sgRNA are 1.645 standard deviations below the mean (z-score < -1.645, P < 0.05) ( Fig. 1G, S5 ; Methods). In all, the integration of SLICE and mux-seq is an efficient and cost-effective strategy for pooled screening and profiling of primary human T cells across many donors.
Heterogeneity of activated CD4 + T cells
Because CD4 + T cells dynamically migrate to and egress from tissues through circulation, cells isolated from PBMCs likely represent a functionally diverse population of cells reflective of the specific immunological state of an individual. This is supported by previous functional genomic analyses of activated primary CD4 + cells demonstrating marked heterogeneity within and variability between individuals in the chromatin and expression profiles that overlap signatures from multiple sorted populations including Th 1 s, Th 2 s, and Th 17 s (18, 22, 33) .
To assess the heterogeneity of activated CD4 + T cells using dscRNA-seq, we clustered 164,623 cells into 10 Leiden clusters (34) with each cluster containing on average 16,462 cells (maximum: 65,720; minimum: 127; Fig. 2A, B) . We identified 2,189 differentially expressed genes in at least one cluster (624±691 per cluster) and annotated each cluster based on the most highly expressed markers. We found a CD27 + /CCR7 + naive T cell population (T naive ) (35, 36) (65,720 cells, 40%), and three effector populations including IL5 + /IL17RB + /GATA3 + Th 2 s (37-45) (1,969, 1.1%), IFNG + Th 1 s (42, 46, 47) (8,022 cells, 4.8%), and PRF1 + /GNLY + /NKG7 + cytotoxic cells (T cyto ) (16) (37,960, 23%) ( Fig. 2C, D) . We also identified three activated populations (Th stim ) defined by the expression of HMGB2 and STMN1 (48, 49) and distinguished from each other by the expression of histone markers (Th stim,histone , 19,920 cells, 12%), cell cycling markers PTTG1 (50, 51) and KIAA0101 (52-54) (Th stim,cycling , 16,905 cells, 10%), and naive markers CCNB1 (55) (T stim,naive , 12,345 cells, 7.4%). We also found a proliferating population (T prolif ) that expressed genes associated with tumor progression, including FXYD5 (56) (57) (58) , LIMD2 (59, 60) , and PFDN5 (61) (903 cells, 0.05%). Finally, we identified two small clusters likely to be transitional, as they are intermediates in lineage trajectory (62) space either between naive and cytotoxic cells (T naive→cyto 752 cells, 0.04%) or between naive and stimulated cells (T naive→stim : 172 cells, 0.01%; Fig. S6 ). To validate these annotations, for each cluster, we correlated the average log fold change in expression of upregulated genes (with respect to all other clusters) to the bulk RNA-seq expression profiles across 45 reference circulating immune populations (22) (Methods). This approach assigned 8/10 clusters to their expected reference population ( Fig. 2E, Methods) . The frequency of each cluster was generally consistent across donors (average pairwise R = 0.94±0.04; Fig. 2F, S7) . These results demonstrate that multiplexed single-cell RNA-sequencing of activated CD4 + T cells recapitulate the expected T cell subpopulations obtained from sorted PBMCs and enables estimates of donor variability in T cell composition.
Regulator perturbations drive T cell polarization
Regulators that control the activation and polarization of specific CD4 + T cell subsets have been mapped in mice and humans using either pooled CRISPR/Cas9 screens sorting for specific cell surface markers or RNA-interference (RNAi) followed by bulk transcriptomic profiling (24, 63) . These assays trade off perturbation throughput (low in RNAi, high in CRISPR/Cas9) and phenotypic resolution (low by cell sorting, high in bulk transcriptomic profiling). Here, we leverage the ability to link CRISPR perturbations to the transcriptomes of single cells using SLICE followed by mux-seq to enable high throughput (hundreds of loci) and high phenotypic resolution (transcriptome wide) mapping of regulators during human CD4 + activation and polarization. We first demonstrate the robustness and performance of our strategy by the following two quality control assessments. One, comparing cells expressing each knockout sgRNA (KO cells) to cells expressing the wild type sgRNAs (WT cells), the expression fold change for the targeted regulator was lower than random genes (FC targeted = 0.56 vs. FC random = 0; KS test; P < 2.26x10 -16 , Fig. 3A) . Second, the transcriptomes of cells expressing sgRNAs targeting the same regulator or WT sgRNAs are more correlated on average (R KO = 0.44, R WT = 0.50) than cells expressing two random sgRNAs (R random = 0; KS test P < 2.2x10 -16 ) ( Fig. 3B) . These two results suggest that sgRNAs targeting the same gene have similar downstream transcriptomic effects despite a modest (albeit statistically significant) change in overall fold change of the targeted genes.
We next assessed the effects of KO sgRNAs on T cell states. Compared to WT cells, the proportion of KO cells is statistically enriched in activated or polarized subsets (e.g. Th stim,naive and Th 1 ) and depleted in the inactivated subsets (e.g. T naive cells and transitional T naive→cyto ; hypergeometric test, FDR < 0.05; Fig. 3C ). In order to quantify the effect of each sgRNA on cell state, we computed the proportion of cells in each cluster that contained a particular sgRNA and identified those sgRNAs significantly enriched or depleted using a Z test ( Fig. 3D ; Table 4 ; Methods). Each cluster had on average 13 sgRNAs depleted (z-score < -1.5, P < 0.1) and 25 sgRNAs enriched (z-score > 1.5, P < 0.1; Fig. S8 ). For example, the sgRNA (cutsite: chr2:96551631, cutting efficiency: 0.47) targeting the RNA-binding protein AT-Rich Interactive Domain-Containing Protein 5A (ARID5A) was enriched in the Th 2 cluster (z-score > 1.5, P = 9.0x10 -3 ; Fig. 3E ,F, top panels) and slightly depleted, although not statistically significantly, in the T naive cluster (z-score <-0.4, P = 0.33). The second ARID5A-targeting sgRNA (cutsite: chr2:96550280, cutting efficiency: 0.097) showed consistent patterns of enrichment in T naive and Th 2 cells (T naive : z-score < -1.5, P < 0.1; Th 2 : z-score > 0.2, P = 0.35) ( Fig. S9) . In contrast, the sgRNA targeting interferon response factor 2 (IRF2; cutsite: chr4:184418577, cutting efficiency: 0.25) was depleted in Th 2 cells (z-score < -1.5, P < 0.1; Fig. 3E , F, right panels). The second IRF2-targeting sgRNA (cutsite: chr4:184418667) had a cutting efficiency of 0.04 and was thus considered a WT sgRNA and is not enriched or depleted in any cluster ( Fig. S5) .
We next estimated the trajectory of polarization from T naive to Th 2 cells using diffusion pseudotime (DPT) and quantified the distribution of ARID5A-targeting (cutsite: chr2:96551631) and IRF2-targeting (cutsite: chr4:184418577) sgRNAs along the trajectory (Methods). The shape of the cumulative distribution function along the DPT is informative of enrichment or depletion of cells along the polarization trajectory. For example, if the cumulative percentage has an earlier increase, then the more likely a group of cells are to be naive and reside at an earlier "time-point". Compared to all cells, cells containing the IRF2-targeting (cutsite: chr4:184418577) sgRNA are less likely to be Th 2 -like as shown by the 98.1% cumulative percentage at ~0.1 DPT ( Fig. 3G) , suggesting that IRF2 could be important for the polarization of T naive cells to Th 2 cells or the maintenance of already polarized Th 2 cells. In contrast, cells containing ARID5A-targeting (cutsite: chr2:96551631) sgRNA had a 90.6% cumulative percentage at ~0.1 DPT, exemplifying a greater enrichment at a later pseudotime (more Th 2like). This suggests that ARID5A may play a role in maintaining the T naive cell phenotype, which is consistent with previous reports (64) (Fig. 3G) .
To validate the IRF2-and ARID5A-targeting phenotypes, we used the Cas9 ribonucleoprotein (RNP) system to knockout GATA3, ARID5A and IRF2 each with two sgRNAs and two non-targeting negative controls under general activation (anti-CD3/CD28) and Th 2 (IL-4, anti-IFNG, anti-IL-12) polarization conditions (Methods). After two weeks of culturing, we used fluorescence-activated cell sorting (FACS) to sort for Th 2 (CD62L + ) and Th 1 (T-bet + ) cells and extracted DNA to assess cutting efficiency for each sample. In activated cells containing IRF2targeting sgRNAs, the proportion of Th 2 s (CD62L + ) was lower (3.81% and 2.02%) compared to non-targeting controls (3.46% and 7.71%) but higher compared to GATA3-targeting cells (1.26% and 0.892%; Fig. 3H, S10) , consistent with the pooled screen results. Further, the proportion of Th 1 s (T-bet + ) was higher in IRF2-targeting cells (10.5% and 8.02%) compared to non-targeting controls (0.87% and 1.93%) and GATA3-targeting cells (6.42% and 7.42%; Fig. 3H, S10) . Interestingly, in Th 2 -polarized cells, there was not a change in the proportion of Th 2 cells (Fig.  S11) . In contrast, in activated and Th 2 polarized cells containing ARID5A-targeting sgRNAs, the proportion of Th 2 cells are slightly higher (10.2% and 6.61%) and the proportion of Th 1 cells remain unchanged (1.83% and 1.27%) ( Fig. 3H, S11) . These results recapitulate the pooled screen with IRF2 acting as a positive regulator and ARID5A as a negative regulator of Th s s. Using a multiplexed pooled screening framework, we were able to harness the high resolution transcriptomic data to help elucidate and validate novel cell state regulators.
Regulators interact to alter gene expression
Activation and polarization of T cells is known to involve the genetic interaction of regulators through direct physical cooperation, competition, and feedback and feedforward regulation of gene expression (65) (66) (67) (68) . For example, BATF and JUN physically interact to regulate transcription in dendritic cells (DCs), T cells, and B cells by jointly interacting with IRFs to bind compound-binding AP-1-IRF consensus elements (AICEs) (69) . However, a map of genetic interactions between regulators that specify T cell function remain uncharted, primarily due to insufficient scalable methods to test for genetic interactions in primary T cells.
RNA interference or CRISPR perturbations followed by bulk RNA-seq allows us to study how genetic perturbations change gene expression on average across a population of cells. Detecting genetic interactions between regulators in this setting would require perturbing multiple regulators and observing non-additive changes in average expression, which is both experimentally and statistically intractable beyond a few regulators. By leveraging the ability to link genetic perturbations with their effects in many cells, we used SLICE followed by mux-seq to estimate the effects of CRISPR perturbations on the correlation between genes across cells to detect genetic interactions between regulators.
Specifically, we sought to map genetic interactions by identifying mutually mediating pairs of regulators, defined as one regulator modifying the correlation between another regulator with a downstream gene. As an example, if knocking out R 1 modifies the correlation between R 2 and G, then directionality is established as R 1 mediates the effect of R 2 on G (Fig. 4A) and vice versa. If R 1 and R 2 mutually mediate each other's effects on G, we call R 1 and R 2 a genetic interaction and R 1 , R 2 , and G as a regulator (R) pair -gene triplet. To statistically detect mediation, we performed a likelihood ratio test between two linear mixed effect models, testing for the interaction term of R 1 (presence of sgRNA targeting R 1 ) and R 2,exp (R 2 expression) (Methods). A significant change in correlation between expression of R 2,exp and a downstream gene suggests R 1 mediates the effect of R 2 on the downstream gene.
We identify four different types of regulator interactions: 1) cooperative activation, where regulators and the target gene are positively correlated in WT cells and uncorrelated in KO cells; 2) cooperative repression, where regulators and the target gene are negatively correlated in WT cells and uncorrelated in KO cells; 3) competitive activation, where regulators and the target gene are uncorrelated in WT cells and are positively correlated in KO cells; and 4) competitive repression, where regulators and target gene are uncorrelated in WT cells and are negatively correlated in KO cells (Fig. 4A) .
We tested 37/140 of the most variably expressed regulators corresponding to total of 666 possible regulator pairs and 1,456,542 possible R pair -gene triplets (Methods). For each regulator, we first identified a set of downstream genes whose correlations with the regulator were affected when the regulator was perturbed using the same linear mixed effect model ( Fig.  4A; Methods) . For 33 of the 37 regulators (4 regulators each had a WT sgRNA), sgRNAs targeting the same regulator were more likely to identify the same downstream targets (P < 0.005, Mann-Whitney U test, Fig. S12 ) with similar changes in correlation (R = 0.31, P = 3.2x10 -78 ; Fig. S13 ) compared to random (R = -0.004, P = 0.56).
To identify R pair -gene triplets, we intersected downstream genes for each regulator pair (FDR < 0.1) and tested for mutual mediation. We identified 310 R pair -gene triplets (FDR < 0.05) where the regulators mutually mediated each other's effect on the downstream gene, comprised of 194 unique regulator pairs ( Fig. 4B; Table 5 ). 24 of the regulator pairs identified were among the 48 regulator pairs previously known to interact (hypergeometric test, P < 0.005) (70) . Combining all candidate genetic interactions reveals a core gene regulatory network in the functionalization of primary T cell ( Fig. 4C ) that suggests JUN, MYC, XBP1, and STAT3/6 forming a central hub with many overlapping interacting partners. To validate the predicted regulator interactions and their downstream targets, we searched for transcription factor binding sites (TFBSs) of the 31 transcription factor (TF) pairs upstream and downstream of each predicted downstream gene's transcription start site (TSS) that exist the Homer database (71) (Methods). We found a greater proportion of downstream gene TSSs containing TFBSs for both TFs compared to random sampling of TF pair -gene triplets (P < 0.05, Kolmogorov-Smirnov test across all windows, Fig. 4D ).
We detected both known and novel interactions between key regulators for T cell functionalization. We identified two possible targets of the previously mentioned BATF-JUN interaction, ATG14 and TMEM204. In addition, we identified an ETS1-STAT6 interaction, which is known to modulate cytokine responses in keratinocytes (69, 72) . While ETS1 has been shown to interact with numerous genes, in particular those in the STAT family, involved in the development and function of T cells (73) , our result specifically suggests STAT6 as an interacting partner.
Amongst the candidate regulator interactions, we identified 23 pairs of cooperative activators, 29 pairs of competitive activators, 109 pairs of competitive repressors, and 149 pairs of competitive activators (Fig. 4E) . In one example of competitive interaction, compared to WT cells, GTF3A is more correlated with genes in cells expressing the CREM-targeting (cutsite: chr10:35179264) sgRNA and CREM is more correlated with genes in cells expressing the GTF3A-targeting (cutsite: chr13:27424803) sgRNA (Fig. 4F) . CREM and GTF3A is an example of a competitive repressor pair that regulates the expression of CLUAP1, where CLUAP1 is negatively correlated with each regulator in KO cells but uncorrelated in WT cells (Fig. 4G) . In another example, MYC and NFATC3 cooperatively interact to activate XRN1 (Fig. 4H) where XRN1 is positively correlated with each regulator in WT cells but not correlated in KO cells (FDR < 0.05). These results suggest that when a regulator is perturbed, downstream effects of other regulators become more prominent and this change can be harnessed to detect subtle interactions, often competitively activating interactions, between regulators.
CRISPR perturbation modifies genetic effects on gene expression
While the contribution of interindividual variability to the composition, expression and activation of CD4 + T cells ex vivo has been described by us (18, 19) and others (20, (74) (75) (76) (77) (78) (79) , little is known about the interindividual variability in CRISPR perturbed cells. Using a linear mixed model, we analyzed cells expressing each sgRNA to identify 125 genes whose expression were variable between individuals (interindividual genes, FDR < 0.2) across 79 sgRNAs (Fig. 5A, B; Table 7 ; Methods).
However, interindividual variability can be attributed to genetic, environmental and technical confounding effects. To identify the genetic contribution, we performed an expression quantitative trait loci (eQTL) analysis using a linear mixed model that includes a genetic covariate term ( Fig. 5A; Methods) . Because of the limited number of samples, we significantly reduced the multiple testing burden by only testing for SNPs +/-100 kb around a TSS with a minor allele frequency > 0.4 and only highly expressed genes per sgRNA (on average 1,891 genes). We found a total of 88 eQTLs (in cis) across cells expressing all sgRNAs (permutation FDR < 0.2) corresponding to 84 genes (eGene) (Fig. 5B) . To assess the robustness of these results, we performed two quality check analyses. First, genes previously reported to have an eQTL in activated CD4 + T cells (18) and with significant interindividual variability were more statistically significant than those that were not (Fig. 5B) . Second, the variance explained by genetics was correlated with and expectedly less than the variance due to interindividual variation amongst eGenes (R = 0.19, P = 0.03, Fig. 5C ).
We next assessed eQTLs detected in KO versus WT cells. Overall, eQTL effect sizes were more correlated between cells expressing sgRNAs targeting the same regulator (R = 0.24, P = 0.003) than between cells expressing a random pair of sgRNAs (R = 0.09, P = 0.2), suggesting genetic effects specific to each knockout (Fig 5D) . For the regulators that exist in the Homer database (71), we found that genes harboring binding sites for 10 regulators are more likely to be eQTLs (as indicated by more significant P) (Fig. 5E) . On average, genetics explained 64% and 56% of the variability in KO and WT cells respectively (Fig. 5F) . Finally, we found eQTLs were more likely to be detected in KO cells (22% of KO vs. 14% of WT sgRNAs; hypergeometric P = 0) (Fig. S14) . These results support that in vitro genetic perturbations by CRISPR/Cas9 can uncover effects of natural genetic variation undetectable in unperturbed cells.
The increased power to detect genetic effects on gene expression only in KO cells could be due to a change in the trans environment or regulator-genetic interactions (cis x trans epistatic interaction) ( Fig. 5G) . If the activity of a regulator has an additive effect on gene expression, then ablating the regulator will decrease the overall variance of gene expression thereby increasing the genetic contribution to gene expression ( Fig. 5F, S15-17 ). Supporting this model, 80 out of the 88 eQTLs had lower standard errors in KO cells compared to WT cells (Fig. S16) .
If the activity of a regulator multiplicatively interacts with genetic variants (epistasis), then ablating the regulator should change the genetic effect on gene expression. To identify instances of epistasis, we fit a linear mixed model testing for cis (SNP) x trans (sgRNA presence or absence) interactions (Fig. 5G) . We found statistical evidence for epistasis for 48 out of 88 eQTLs (FDR < 0.05), where the sgRNA is more likely to interact with the eQTL than a random SNP (Fig. 5H) . These results suggest that CRISPR/Cas9 ablation of a regulator can uncover both additive and epistatic effects from standing genetic variation on gene expression.
As an illustrative example, we found evidence for an epistatic interaction between IRF1targeting (cutsite: chr5:132487047) sgRNA and genetic variant (rs1885125) to regulate MCM9 expression ( Fig. 5H) . IRF1 (also known as interferon regulatory factor 1) has previously been shown to regulate T cell activation (80) (81) (82) , particularly driving Th 1 polarization (83) . Two independent epigenetic analyses suggest IRF1 binding at the MCM9 promoter ( Fig. S18) . First, in K562 cells, there is an IRF1 ChIP-seq peak 142 bp upstream from rs1885125, containing four SNPs in LD (D' > 0.97). Second, the Homer database (71) predicted an IRF1 binding site 595 bp upstream from rs1885125 using an IRF1 ChIP-seq in peripheral blood mononuclear cells, which is flanked by rs4946371 (D' > 0.98). These results support the interaction between a genetic variant in a cis regulatory element of MCM9 and the trans factor, IRF1, to account for 47% of MCM9 expression variability. All together, these results suggest that CRISPR perturbations can uncover interindividual variation in gene expression and in some cases, epistatically interact with natural standing variation to modulate the variability of gene expression.
Discussions
CD4 + T cells serve diverse roles in the adaptive immune system by dynamically responding to extracellular signals in their microenvironment. While the gene regulatory networks governing these responses have been extensively studied in mice, the topology and parameters of these networks, including how they vary across individuals, have not been mapped in humans. To address these gaps, we present the first large scale, multiplexed single cell RNA-seq study of activated primary CD4 + T cells isolated from 9 donors across CRISPR perturbations targeting hundreds of candidate regulators.
Activated CD4 + T cells are heterogeneous, capturing cell states reminiscent of canonical helper subtypes (e.g. Th 1 , Th 2 , etc), cytotoxic phenotypes, and broad activation or cell cycle. We find that cells expressing WT sgRNAs are more likely to be T naive cells while those expressing KO sgRNAs are more likely to promote polarization into a differentiated state (e.g. Th 1/2 cells), exemplified by the identification ARID5A as a negative regulator of Th 2 polarization. We expect that the application of our approach to cells differentiated or polarized under specific conditions (e.g. toward a Th 2 phenotype) rather than broad activation (e.g. anti-CD3/CD28 activation) can further refine the mapping of gene regulatory programs that control T cell differentiation, polarization and maintenance.
The identification of gene gene interactions is experimentally and combinatorially challenging in primary cells. By exploiting coexpression patterns between single cells, we devised a new approach based on differential correlation analysis to detect interactions between pairs of regulator during T cell activation and polarization. Using this approach, we reconstructed a gene regulatory network for T cell activation that includes known interactions (e.g. JUN, MYC, XBP1, STAT) and previously unreported interactions such as between ETS1 and STAT6, which may be involved in the propagation of T cell cytokine signaling. By increasing the number of cells profiled using multiplexed workflows (30, 84) and the number of genetic perturbations through higher multiplicity of infection (85) , future integration of genome engineering and single cell transcriptomics would allow for refined mapping and causal reconstruction (86) of gene regulatory networks in specific low frequency T cell subsets (e.g., Th 1/2 , T naive ). (86) Although epistatic interactions involving naturally segregating variants have been identified in model organisms, there has been been limited success in identifying these interactions using observational studies in humans due to limited power (87) (88) (89) . Our genetic-multiplexed approach allowed us to identify genes that are interindividual variable in CRISPR perturbed primary human cells and in some cases, pinpoint the genetic variants that likely mediate the variability. Akin to reducing the trans contribution of gene expression through in vitro perturbations (18) (19) (20) 90) or computational adjustments (91), we provide evidence of decreased gene expression variance in CRISPR perturbed cells thus increasing the ability to detect cis genetic effects. Surprisingly, we also found that some CRISPR perturbations can modify the effects of genetic variants on gene expression epistatically reminiscent of gene by environment effects detected by in vitro perturbation of cells (18) (19) (20) 90) . Thus, a comprehensive perturbative-QTL analysis using CRISPR/Cas9 is a compelling alternative strategy to large observational studies for mapping genetic interactions that involve standing genetic variants in primary human cells.
Our work provides the first view into the heterogeneity of activated CD4 + T cells at the single cell resolution across pooled CRISPR perturbations and individuals. We identify candidate regulators of T cell polarization and two classes of genetic interactions. By harnessing natural and CRISPR genome engineering, we can begin to efficiently dissect gene regulatory networks and identify genetic interactions in primary human cells. 
